A Phase 4 interventional study of Optive in Dry Eye Syndromes, sponsored by Innovative Medical. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2008-04-17.
Sponsored by Innovative Medical · Phase 4, Interventional, and Supportive care
To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.
1,292 studies on the registry are indexed under Dry Eye Syndromes; 192 are open to participants now.
This study's enrollment of 92 is above the median of 60 across 1,077 interventional studies indexed under Dry Eye Syndromes.
Browse Dry Eye Syndromes studies →Innovative Medical is the lead sponsor of 50 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Use of systemic medications with ocular drying sequelae:
Drug: Optive
Optive 30ml- (in the eye) Instill one in each eye twice daily starting one week after surgery
Assess compatibility
Time frame: 8 months
comfort
Time frame: 8 months
This study is completed, as verified in Apr 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Innovative Medical